Changing interpretations, stable genes: responsibilities of patients, professionals, and policy makers in the clinical interpretation of complex genetic information

作者: Brian H Shirts , Lisa S Parker , None

DOI: 10.1097/GIM.0B013E31818BB38F

关键词:

摘要: Except in rare mutation-inducing events, the primary sequence of an individual's somatic genome is static; however, interpretations or risk predictions based on complex genetic tests now being introduced into marketplace are rapidly changing. The reality changing for stable test results creates questions everyone involved testing including individuals, clinicians, laboratories, professional organizations, and regulators. Individuals should be aware that their relationship with laboratories providing may different from physician, especially direct-to-consumer testing. Moreover, individuals need to take initiative revisit periodically. Clinicians will learn how read interpret tests, remember change over time, understand when refer patients specialists ask second opinions reinterpretation information. Testing they replacing clinician as direct contact patients, have responsibility inform clients changes interpretation. At minimum, make clear what policies regarding allow tested seek outside results. Professional organizations regulators develop guidelines general public. In future, interpretation relatively stable; until static create important set ethical challenges.

参考文章(15)
Béatrice Godard, Martin Letendre, Expanding the physician's duty of care: a duty to recontact? Medicine and law. ,vol. 23, pp. 531- ,(2004)
J LANCASTER, C BETHANPOWELL, N KAUFF, I CASS, L CHEN, K LU, D MUTCH, A BERCHUCK, B KARLAN, T HERZOG, Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecologic Oncology. ,vol. 107, pp. 159- 162 ,(2007) , 10.1016/J.YGYNO.2007.09.031
Jennifer L. Fitzpatrick, Cecil Hahn, Teresa Costa, Marlene J. Huggins, The Duty to Recontact: Attitudes of Genetics Service Providers American Journal of Human Genetics. ,vol. 64, pp. 852- 860 ,(1999) , 10.1086/302293
W Gregory Feero, Alan E Guttmacher, Francis S Collins, The Genome Gets Personal—Almost JAMA. ,vol. 299, pp. 1351- 1352 ,(2008) , 10.1001/JAMA.299.11.1351
Prakash Gorroochurn, Susan E Hodge, Gary A Heiman, Martina Durner, David A Greenberg, Non-replication of association studies: "pseudo-failures" to replicate? Genetics in Medicine. ,vol. 9, pp. 325- 331 ,(2007) , 10.1097/GIM.0B013E3180676D79
C Sue Richards, Sherri Bale, Daniel B Bellissimo, Soma Das, Wayne W Grody, Madhuri R Hegde, Elaine Lyon, Brian E Ward, None, ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 Genetics in Medicine. ,vol. 10, pp. 294- 300 ,(2008) , 10.1097/GIM.0B013E31816B5CAE
R. A. Smith, V. Cokkinides, O. W. Brawley, Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues. CA: A Cancer Journal for Clinicians. ,vol. 58, pp. 161- 179 ,(2008) , 10.3322/CA.2007.0017
Alasdair G.W. Hunter, Neil Sharpe, Michelle Mullen, Wendy S. Meschino, Ethical, legal, and practical concerns about recontacting patients to inform them of new information: The case in medical genetics American Journal of Medical Genetics. ,vol. 103, pp. 265- 276 ,(2001) , 10.1002/AJMG.1568
Kenneth Offit, Genomic Profiles for Disease Risk JAMA. ,vol. 299, pp. 1353- 1355 ,(2008) , 10.1001/JAMA.299.11.1353
Christopher H. Wade, Benjamin S. Wilfond, Ethical and clinical practice considerations for genetic counselors related to direct-to-consumer marketing of genetic tests American Journal of Medical Genetics Part C: Seminars in Medical Genetics. ,vol. 142C, pp. 284- 292 ,(2006) , 10.1002/AJMG.C.30110